Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure of a DNA-bisdaunomycin complex

G G Hu1, X Shui, F Leng

  • 1School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta 30332-0400, USA.

Biochemistry
|May 20, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sudomotor dysfunction is associated with impaired left ventricular diastolic function in persons with type 2 diabetes: a cross-sectional study.

Journal of endocrinological investigation·2023
Same author

[Resection of submandibular gland and tumor via transaxillary gasless endoscopy: a case report].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2022
Same author

[Virtual reality-assisted management of communicated solitary fibrous tumor in skull base: a case report].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2022
Same author

Engineering new limits to magnetostriction through metastability in iron-gallium alloys.

Nature communications·2021
Same author

2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.

International journal of molecular sciences·2020
Same author

Curcumin as tyrosine kinase inhibitor in cancer treatment.

European journal of medicinal chemistry·2019

A new bisanthracycline drug, WP631, successfully binds DNA as designed, forming ultratight complexes. X-ray crystallography revealed how this bis-intercalation differs from traditional daunomycin binding, offering insights into drug-DNA interactions.

Area of Science:

  • Medicinal Chemistry
  • Structural Biology
  • Molecular Pharmacology

Background:

  • Detailed structural databases enabled the design of novel bisanthracyclines.
  • These new compounds aim to form ultratight DNA complexes, improving therapeutic potential.
  • Daunomycin dimers were conceptualized to mimic monomer binding at adjacent DNA sites.

Purpose of the Study:

  • To determine if the bisanthracycline WP631 binds DNA as intended using X-ray crystallography.
  • To elucidate the molecular-level binding mode of WP631.
  • To compare mono- and bis-intercalated DNA complexes of the same chromophore.

Main Methods:

  • X-ray crystallography was employed to solve the 2.2 Å structure of the WP631-DNA complex.
  • The study utilized a synthetic DNA dodecamer, [d(CGATCG)]2.

Related Experiment Videos

  • Structural analysis focused on comparing the binding of WP631 with daunomycin.

    • Main Results:

    • The X-ray crystal structure confirmed the successful design and binding strategy of WP631.
    • Detailed molecular insights into the bis-intercalation of WP631 into DNA were obtained.
    • Differences in DNA distortion were observed between mono-intercalated daunomycin and bis-intercalated WP631 complexes.

    Conclusions:

    • The design strategy for bisanthracyclines like WP631, aiming for ultratight DNA binding, is validated.
    • The study provides a unique comparison of mono- versus bis-intercalation at the molecular level.
    • Bis-intercalation leads to more efficient propagation of DNA unwinding and helical distortions towards the complex center.